title: Downregulation of interleukin-12p35 and upregulation of interleukin-12p40 mRNA expression in heart allografts by blood transfusion from granulocyte colony-stimulating factor-treated donors.
abstract: Pretransplant treatment of recipients with recombinant human granulocyte colony-stimulating factor (rhG-CSF, 250 microg/kg/day s.c. for 5 days) facilitates heart allograft acceptance in tacrolimus-treated rat recipients. We examined effectiveness of transfusion of in vivo rhG-CSF-treated blood since rhG-CSF induces immunoregulatory cells in human blood. DA heart grafts were transplanted into tacrolimus (2 mg/kg i.m. on day 0)-treated Lewis recipients. Although graft survival prolongation by blood transfusion on day 0 from rhG-CSF-treated syngeneic Lewis was comparable to that in directly rhG-CSF-pretreated recipients (p = 0.22), transfusion of rhG-CSF-treated allogeneic DA blood was much more effective (p = 0.0016). Intragraft cytokine mRNA levels were measured by reverse transcription and real-time polymerase chain reaction at 24 h after transplantation. IL-12p35 expression was downregulated by both treatments. Notably, IL-12p40 was upregulated by rhG-CSF-treated DA blood transfusion but downregulated by transfusion of rhG-CSF-treated isogeneic blood. Differential expression of IL-12 subunits was associated with facilitation of graft acceptance by rhG-CSF-treated donor blood transfusion.
authors.affiliation: Department of Surgery, Division of Frontier Medical Science, Graduate School of Biomedical Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan.
authors.forename: Ichiro
authors.initials: I
authors.lastname: Ohmori
authors.forename: Keisuke
authors.initials: K
authors.lastname: Hayamizu
authors.forename: Teruhiko
authors.initials: T
authors.lastname: Kitayama
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Egi
authors.forename: Xuehelati
authors.initials: X
authors.lastname: Aihaiti
authors.forename: Toshimasa
authors.initials: T
authors.lastname: Asahara
mesh_terms: D000818:Animals; D001803:Blood Transfusion; D015536:Down-Regulation; D004797:Enzyme-Linked Immunosorbent Assay; D006085:Graft Survival; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D016027:Heart Transplantation; D006801:Humans; D018664:Interleukin-12 / Q000096:biosynthesis*; D053765:Interleukin-12 Subunit p35; D053762:Interleukin-12 Subunit p40; D008297:Male; D021122:Protein Subunits / Q000096:biosynthesis*; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013045:Species Specificity; D016559:Tacrolimus / Q000494:pharmacology; D013997:Time Factors; D019172:Transplantation Conditioning; D015854:Up-Regulation
chemical_list: C508858:IL12A protein, human; D053765:Interleukin-12 Subunit p35; D053762:Interleukin-12 Subunit p40; D021122:Protein Subunits; D012333:RNA, Messenger; D016179:Granulocyte Colony-Stimulating Factor; D018664:Interleukin-12; D016559:Tacrolimus